A startup valuation calculator is a decision framework — not a single formula — that produces a defensible pre-money valuation by applying the method that fits your stage, revenue profile, and buyer. Founders raising a $2M seed round need a very different calculation than an operator selling a $30M ARR SaaS to a strategic acquirer. This guide walks through six stage-appropriate methods, the inputs each one requires, and the 2025–2026 benchmarks you should be pricing against.

The stakes are concrete. Carta's State of Private Markets: 2025 in Review found that median seed post-money valuations hit $24M in Q4 2025, and median Series A post-money reached $78.7M — with an AI premium of 38% at Series A and 193% at Series E+. A one-turn error on the multiple you defend in a term-sheet conversation is a seven-figure mistake on dilution. A startup valuation calculator that picks the right method for your stage protects that number.

Why Stage Determines Method (and a Single Calculator Won't Do)

Every method below optimizes for a different information environment. Pre-revenue founders have no cash flows to discount, so DCF is theater. A Series C SaaS with $40M ARR and 130% net revenue retention has too much signal for a Berkus scorecard to add value. The mistake most spreadsheet-only valuation calculators make is forcing one lens onto every stage.

A practical rule, sourced from the Angel Capital Association's own guidance on Bill Payne's Scorecard Method and echoed across Carta's quarterly reports:

  • Idea / pre-prototype: Berkus Method
  • Pre-revenue with team + traction signal: Scorecard (Bill Payne) Method
  • Seed to Series A with a target exit thesis: Venture Capital Method
  • Series A / B with named comparables: Comparable Company Analysis
  • Revenue-generating SaaS / recurring-revenue business: Revenue Multiple (ARR/EV) Method
  • Series C+ with predictable cash flow: Discounted Cash Flow (DCF)

Actionable next step: Before you build any model, map your business against the six stages above and pick the top two methods. You'll triangulate a valuation range using both, and defend the number that sits inside the overlap.

Method 1: The Berkus Method — Pre-Revenue Idea-Stage

Developed by super-angel Dave Berkus and codified by the Angel Capital Association, this method assigns up to $500,000 of value to each of five qualitative risk-reducers, capping a pre-money valuation at $2.5M. It exists so founders and angels can agree a number when there is literally no revenue to multiply.

The five categories, each worth up to $500K:

  1. Sound idea (basic value, product risk): Is the problem real? Is the solution technically feasible?
  2. Prototype (reduces technology risk): Does something exist that a customer could touch?
  3. Quality management team (reduces execution risk): Have any of the founders done this before?
  4. Strategic relationships (reduces market risk): Do you have distribution, LOIs, or channel partners lined up?
  5. Product rollout or sales (reduces production risk): Any paying pilots?

Worked example: A founder with a working prototype ($400K), two ex-Stripe engineers ($450K), one signed LOI from a mid-market design partner ($300K), and a plausible market thesis ($400K), no rollout yet ($0), lands at a $1.55M pre-money. That is roughly what a US pre-seed founder would defend at the low end of Equidam's Q1 2026 US pre-seed dataset (median $7.64M, but that median includes AI companies pulling the top up).

Takeaway: Use Berkus when you have no revenue and need a defensible floor. Do not use it once a paying customer exists — the ceiling is too low.

Method 2: The Scorecard (Bill Payne) Method — Pre-Revenue With a Region Comparable

Bill Payne published the Scorecard Method in 2001 and the Angel Capital Association still teaches it as the default for pre-revenue angel deals. The method has one advantage the Berkus doesn't: it anchors on a regional pre-money median that moves with the market, so the number automatically updates as valuations expand or compress.

The three steps:

  1. Get the median pre-money valuation for pre-revenue startups in your region and sector. In 2025, that number for US pre-seed sat between $6M and $8M depending on the dataset (Carta, Equidam, Zeni).
  2. Score your startup against the region on Payne's six weighted factors: management (30%), size of opportunity (25%), product/technology (15%), competitive environment (10%), marketing/sales/partnerships (10%), need for additional investment (5%), other (5%).
  3. Multiply the region median by the weighted score. A startup that scores 1.25x on management, 1.5x on opportunity, and 1.0x elsewhere lands at approximately 1.19x the median.

Worked example: Region median = $7M. Weighted score = 1.19. Pre-money = $8.33M.

Takeaway: Scorecard is the honest default when you have team quality and market thesis but no revenue. Rebuild the region median every quarter using the latest Carta report — using stale medians is the most common Scorecard error.

Method 3: The Venture Capital Method — Seed and Series A

The VC Method, formalized in Harvard Business School case notes in the 1980s and still taught in every VC training program, works backward from a target exit value. It is the method the person on the other side of your term sheet is actually running.

The formula, in four steps:

  1. Estimate exit value: Terminal ARR × exit multiple. Example: $40M ARR in year 5 × 6x = $240M exit.
  2. Discount to today: Divide by required ROI. Seed funds target 10x, Series A funds 5–7x. At 10x, post-money today = $24M.
  3. Subtract new investment: Post-money − round size = pre-money. $24M − $4M = $20M pre-money.
  4. Adjust for dilution: Bake in future rounds (typical assumption: 25–30% additional dilution per subsequent round) before you finalize.

2026 anchor: Carta's Q4 2025 report shows median seed post-money at $24M — meaning most seed founders raising $4–6M are defending a $20M pre-money using exactly this math.

Takeaway: Build a spreadsheet model with three exit-multiple scenarios (conservative 4x, base 6x, bull 10x ARR). Show the same pre-money holding across the base case. That symmetry is what makes a term sheet defensible.

Method 4: Comparable Company Analysis — Series A Through Growth

Comparable company analysis (comps) is the workhorse of investment banking and the second-most-common method venture investors use after the VC Method. You find recently funded companies at the same stage, in the same sector, with similar growth and gross margin, and you adjust their valuation to yours.

The step-by-step:

  1. Pull 8–12 recent primary rounds in your sector at your stage. Carta's quarterly State of Private Markets reports and PitchBook/Crunchbase are the standard sources.
  2. For each comp, compute the operating multiple: EV / ARR, EV / GMV, or EV / revenue depending on business model.
  3. Adjust for the three drivers that explain most of the variance: growth rate, gross margin, and net revenue retention.
  4. Apply the adjusted multiple to your own metric.

Worked example: A Series A vertical SaaS with $3M ARR growing 180% YoY, 78% gross margin. Median Series A SaaS in Carta's Q3 2025 dataset traded around 15–20x forward ARR. Apply an 18x multiple to a $5M forward ARR estimate = $90M post-money. That sits above Carta's overall Q4 2025 median of $78.7M — defensible because growth is above the median for the cohort.

Takeaway: Comps only work if the comps are real. Never use "similar companies I've heard about"; pull actual round data from Carta, PitchBook, or SEC filings for public floor references.

Method 5: The Revenue Multiple Method — SaaS and Recurring Revenue

For a SaaS or subscription business, the market has largely settled on a single number: EV / ARR. What that multiple should be is a function of growth, retention, and margin — and the public market anchor.

The 2026 benchmarks that matter:

  • Bessemer's BVP Nasdaq Emerging Cloud Index (August 2026): average EV/Revenue of 8.4x across 60–80 public cloud constituents.
  • SaaS Capital Index (July 2026): median public SaaS multiple around 3.8x — a reminder that "average" and "median" tell very different stories, and the average is pulled up by a handful of AI leaders.
  • Private SaaS (2025): median 4.8x ARR bootstrapped, 5.3x equity-backed. Strong companies (100%+ growth, 120%+ NRR) reach 8–10x. Companies with sub-100% NRR cap around 3–4x.

Worked example: A $10M ARR vertical SaaS growing 60% YoY with 115% NRR and 82% gross margin sits in the top quartile of private SaaS. Apply 7x = $70M enterprise value. Add net cash and subtract debt to move from EV to equity value.

Takeaway: If your NRR is below 100%, fix that before you raise. Retention is the single biggest driver of your multiple in the current market — it's the difference between a 3x and a 7x number on the same ARR.

Method 6: Discounted Cash Flow (DCF) — Series C and Beyond

DCF is the method Aswath Damodaran teaches at NYU Stern and the one every M&A banker builds when a company has predictable cash flows. It is also the method that returns nonsense when applied to a pre-revenue startup — Damodaran himself notes that traditional DCF techniques "either do not work or yield unrealistic numbers when applied to young companies."

The build, in five steps:

  1. Project unlevered free cash flow for 5–10 years. Use narrative-anchored assumptions (Damodaran's "3P test": possible, plausible, probable).
  2. Compute a terminal value using either a perpetuity growth model (Gordon growth) or an exit multiple.
  3. Pick a discount rate. For late-stage startups, WACC of 12–15% is defensible; for earlier stages, Damodaran advocates layering explicit failure-risk adjustments (a 20–30% probability of ruin) rather than inflating the discount rate.
  4. Discount cash flows plus terminal value to present.
  5. Sensitivity-test with a two-way table on growth rate and discount rate. The valuation range is what you defend.

Takeaway: Only run DCF when you have three years of actual financials and a credible five-year plan. Before that, use it as a sanity check on the VC Method, not as the primary output.

Triangulating the Final Number

No serious operator picks one method and stops. The move is to run two methods appropriate to your stage, look for overlap, and defend the number in that overlap. A Series A SaaS founder should run the VC Method (working back from a target exit) and Comparable Company Analysis (validating against real recent rounds). If the two produce $18M and $22M pre-money, you defend $20M — and you'll have both models on hand when the term sheet negotiation starts.

The 2025–2026 environment rewards this rigor. Carta's data shows down rounds fell to 17% in Q3 2025 — the lowest in three years — but the bar to qualify for premium valuations rose in parallel. A founder who walks in with a single method and a hopeful number is negotiating against a partner who has run all six.

Building each of these models from scratch in Excel takes 20–40 hours if you know what you're doing and considerably longer if you don't. A ready-made ModelStack valuation template gives you all six methods pre-wired to a single input tab — enter your ARR, growth rate, and target exit multiple, and every method updates in parallel. That is the fastest way to walk into a fundraise with a defensible number and the receipts to back it up.

Sources

Client.listTools() called but server does not advertise tools capability - returning empty list

Related: Browse all VC & Startup Templates on ModelStack.

Get started with a free template

Download our free Unit Economics Calculator — no signup required.

Download Free Template